so let's break this down a bit: 'In addition to the cannabis...

so let's break this down a bit:

'In addition to the cannabis research licence the company, on 8 March 2017 Cann was issued Australia’s first Medicinal Cannabis Cultivation Licence. The new licence allows Cann Group to produce Australian grown material that can be prescribed for patient use.'
So already they have Licences that QBL so desperately requires..'

Really, is QBL desperate for this now that they have an exclusive licence to any MM products developed by one of the best MM research teams in the world (35 scientists working away)...I'd put them up against anything CAN can come up with...so no...not desperate at all, and in fact teaming with an institution that is known for its ability to commercialise

'They also have an import /export licence granted by the ODC'

Yes, QBL has told you they are applying for this for Canntab and has indicated the timeframes involved for you and are still well within them...so what's your point given that you have said this ad nauseam

'So there's three things QBL is trying to achieve but hasn't yet..'

Incorrect, and CAN cannot import Canntab with their import licence and therefore QBL does not want CAN's import or export licence...only QBL will be able to once granted

'They harvested crops already in Aug 2017 and are working with the CSIRO for clinical trials'

CAN gets zero income from these crops or next to nothing...correct? Working with the CSIRO for clinical trials...lol...QBL is operating on a global scale regarding the MM through their world renowned MM research team...and no, this is not puffing up the QBL research team...go do your research on them

'Cann Group is producing medicinal cannabis for subsequent manufacturing into a final product that can be accessed by patients via clinical trials, or through the TGA’s Authorised Prescriber or Special Access Scheme.'

Just what products are they benny? you that are apparently so worried about the uncertainties. you really don't have any idea what they are yet or will be, do you?...at least we know what QBL is going for and CAN has no rights to Canntab at all.

'These guys are purely a MM company and they have already got the licences they need.... With QBL still waiting for these and the time frames for clinical trials they'll have to go through I don't see Canntabs pills on the Market anytime soon..'

That's right CAN do, but unfortunately little prospect for CAN of any income for possibly years to come and just more capital raisings and dilution for shareholders in the pipeline. QBL...already going to be making money from big hemp crops in 2018 while the MM research by one of the most formidable research teams continues unabated self-funded.

Now let's just compare those two market caps again...CAN $400m+...QBL less than $80m...and yet QBL stacks up better than CAN imo

Get a grip benny if that's the best you can come up with...you have been completely debunked once again